Exam 2 - MOAs Flashcards

(29 cards)

1
Q

Inhaled corticosteroids MOA

A

Mimics the function of cortisol which is produced by the adrenal cortex

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Inhaled corticosteroids action/MOA in asthma/COPD

A

Decreased cytokine production

Increased expression of B2 receptors (gene transcription)

Decreased Vascular permeability (endothelial cells start to separate when exposed to histamines/bradykinins)

Decreased mucous secretions

Decreased eicosanoid (PGs-prostaglandins, LTs-leukotrienes) production

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Inhaled corticosteroids metabolism

A

Most have high first pass metabolism, therefore a lower risk of drug induced Cushing’s

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Beta 2 Agonist (LABA, SABA) MOA

A
  1. Stimulates alpha subunit (Gs)
  2. Gs activates adenyl cyclase
  3. Inc cAMP activates PKA
  4. PKA inhibits MLCK (smooth muscle relaxation) which leads to bronchodilation

Other notes: Both mimic epi effects on broncho –
Relaxation or bronchiolar smooth muscle, decreased mast cell degranulation, decrease release of inflammatory cytokines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

SSRI MOA

A

Inhibition of 5HT reuptake transporter (SERT)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

SNRIs MOA

A

Blocks SERT and NET activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

SSRI drug examples

A

Mnemonic:
Pretty Please Call Lexie Zebra

Paxil, Prozac, Celexa, Lexapro, and Zoloft

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

SNRIs drug examples

A

Mnemonic: Cymbalta can Effect your Physique

Cymbalta, Effexor, Pristiq

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

NDRI MOA

A

increases synaptic NE and DA activity & noncompetitive antagonist for nicotinic receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

NDRI Drug example

A

Wellbutrin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Atypical CNS1 MOA

A

Alpha-2 adrenergic antagonist that blocks presynaptic receptors to elevate NE and 5HT in synapses; also blocks postsynaptic 5HT2 receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Example of Atypical CNS1

A

Mirtazapine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

TCA drug MOA

A

blocks NE and 5HT uptake into presynaptic nerve terminal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

TCA drug examples

A

Amitriptyline and nortriptyline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

First gen antipsychotics

A

block DA receptors

Haldol, Compazine/Antiemetics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Second gen antipsychotics MOA

A

blocks 5HT2 receptors and moderate blockade of DA receptors

Note: Abilify is the only a partial agonist of DA

17
Q

Second gen antipsychotics drug examples

A

Zebras Rarely Go (to) San Antonio

Zyprexa, Risperidol, Geodon, Seroquel, Abilify

18
Q

Benzo MOA

A

positive allosteric modulator (PAM) of GABA at GABA-A receptors

Think: some benzos end in “-pam”

19
Q

Buspar MOA

A

partial agonist of 5HT1A

20
Q

Z compounds (esZOpiclone) MOA

A

allosteric modulator of benzo at GABA site (just a different subunit on benzo part)

21
Q

Flumazenil MOA

A

benzo receptor antagonist on GABA-A receptor to block GABA

22
Q

Phenytoin MOA

A

inhibits voltage-gated Na channels of excitatory neurons

23
Q

Carbamazepine/oxcarbazepine MOA

A

inhibits voltage-gated Na channels of excitatory neurons

24
Q

Gabapentinoids MOA

A

inhibit voltage gated Ca channels to decrease excitatory NT release

25
Topiramate (Topamax) MOA
Multi MOAs - inhibits voltage-gated Na channels, inhibits glutamate AMPA receptors
26
Valproate & divalproex MOA
inhibition of GABA-T breakdown and inhibition of voltage-gated Na channels
27
Aricept MOA
acetylcholinesterase inhibitor for Alzheimer’s disease
28
Carbidopa/Levodopa MOA
Dopamine precursor
29
Requip & Mirapex MOA
DA2 receptor agonists